Page 22 - Iontech News Today

Pizer and its partner BioNTech announced plans on Wednesday to develop a vaccine that will work against SARS-CoV-2 (the virus that causes COVID-19) and the entire class, or family, of related coronaviruses.

COVID-19 vaccines for children 6 months and older are now available through community health centers, according to the Joint Information Center.

105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses Pfizer Inc. (NYSE: PFE) and BioNTech

Pfizer and BioNTech announced that their two Omicron-targeted vaccines are safe and effective against the coronavirus, including the latest Omicron subvariants. This new formulation could be used as a fourth shot — or a second booster — to better protect against another coronavirus surge expected this fall and winter.

Omicron-adapted monovalent candidate given as a fourth booster dose elicited a 13.5 and 19.6-fold increase in neutralizing geometric titers against Omicron BA.1 at 30 µg and 60 µg dose levels; bivalent

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and BioNTech SE (BNTX) announced positive data from the Phase 2/3 trial evaluating the safety, tolerability, and immunogenicity of Omicron-adapted COVID-19

25.06.2022 - Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive data evaluating the safety, tolerability, and immunogenicity of two Omicron-adapted COVID-19 vaccine candidates: one monovalent and the other bivalent, a combination of ...

Children 6 months and older can now get their COVID-19 vaccine, a federal group decided...

In a Phase 2/3 clinical trial, the Pfizer-BioNTech COVID-19 Vaccine elicited a strong immune response in this age group Three 3-µg doses had favorable safety profile similar to placebo in

What to know about COVID vaccines for young children